Definition of oxaliplatin sensitivity in patients with advanced colorectal cancer previously treated with oxaliplatin-based therapy

被引：0
|
作者：
de Gramont Lesparre, A. H. [1 ,2 ,3 ,4 ]
Chibaudel, B. [1 ,2 ,3 ,4 ]
Bourges, O. [1 ,2 ,3 ,4 ]
Perez-Staub, N. [1 ,2 ,3 ,4 ]
Tournigand, C. [1 ,2 ,3 ,4 ]
Maindrault-Goebel, F. [1 ,2 ,3 ,4 ]
Andre, T. [1 ,2 ,3 ,4 ]
Larsen, A. K. [1 ,2 ,3 ,4 ]
Afchain, P. [1 ,2 ,3 ,4 ]
Louvet, C. [1 ,2 ,3 ,4 ]
机构：
[1] Hop St Antoine, F-75571 Paris, France
[2] GERCOR, Multidisciplinary Grp Canc Res, Paris, France
[3] Hop La Pitie Salpetriere, Paris, France
[4] INSERM, Paris, France
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2009年 / 27卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4024
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Oxaliplatin-based chemotherapy inpatients with advanced pancreatic cancer
    Vattemi, E.
    Franchi, R.
    Pedersini, R.
    Tansini, G.
    Baier, S.
    Costa, P.
    Signaroldi, A.
    Zanaletti, F.
    Sbalzarini, G.
    Graiff, C.
    ANNALS OF ONCOLOGY, 2006, 17 : 34 - 34
  • [22] Phase II study of an oxaliplatin-based regimen for relapsed colon cancer patients treated with oxaliplatin-based adjuvant chemotherapy (INSPIRE study)
    Keiichiro Ishibashi
    Toru Aoyama
    Masahito Kotaka
    Hironaga Satake
    Yasushi Tsuji
    Masato Kataoka
    Masato Nakamura
    Naoki Nagata
    Junichi Sakamoto
    Koji Oba
    Hideyuki Mishima
    Cancer Chemotherapy and Pharmacology, 2021, 87 : 665 - 672
  • [23] Phase II study of an oxaliplatin-based regimen for relapsed colon cancer patients treated with oxaliplatin-based adjuvant chemotherapy (INSPIRE study)
    Ishibashi, Keiichiro
    Aoyama, Toru
    Kotaka, Masahito
    Satake, Hironaga
    Tsuji, Yasushi
    Kataoka, Masato
    Nakamura, Masato
    Nagata, Naoki
    Sakamoto, Junichi
    Oba, Koji
    Mishima, Hideyuki
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2021, 87 (05) : 665 - 672
  • [24] Advanced colorectal cancer (ACRC) in elderly patients: Evaluation of three different oxaliplatin-based chemotherapy regimens
    Pinto, Carmine
    Di Fabio, Francesca
    Gentile, Anna Lisa
    Mini, Enrico
    Giaquinta, Stefania
    Llimpe, Fabiola Lorena Rojas
    Mutri, Vita
    Piana, Edera
    Mazzei, Teresita
    Martoni, Andrea
    ANNALS OF ONCOLOGY, 2005, 16 : 47 - 47
  • [25] Reinduction of oxaliplatin-based chemotherapy after exposure to oxaliplatin in adjuvant setting for colorectal cancer.
    Beom, Seung-Hoon
    Ahn, Joong Bae
    Shin, Sang Joon
    Jung, Minkyu
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (04)
  • [26] Role of Calcium/Magnesium Infusion in Oxaliplatin-Based Chemotherapy for Colorectal Cancer Patients
    Kurniali, Peter C.
    Luo, Lu Guang
    Weitberg, Alan B.
    ONCOLOGY-NEW YORK, 2010, 24 (03): : 289 - 292
  • [27] Oxaliplatin-based chemotherapy in the treatment of elderly patients with metastatic colorectal cancer (CRC)
    Berretta, Massimiliano
    Zanet, Ernesto
    Nasti, Guglielmo
    Lleshi, Arben
    Frustaci, Sergio
    Fiorica, Francesco
    Bearz, Alessandra
    Talamini, Renato
    Lestuzzi, Chiara
    Lazzarini, Renzo
    Fisichella, Rossella
    Cannizzaro, Renato
    Iaffaioli, Rosario Vincenzo
    Berretta, Salvatore
    Tirelli, Umberto
    ARCHIVES OF GERONTOLOGY AND GERIATRICS, 2012, 55 (02) : 271 - 275
  • [28] META-ANALYSIS ON THE PREDICTIVE VALUE OF PHARMACOGENETIC MARKERS OF OXALIPLATIN-BASED THERAPY FOR COLORECTAL CANCER PATIENTS
    Ridha, Z.
    Shahnam, A.
    Wiese, M.
    Kichenadasse, G.
    Sorich, M.
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2016, 12 : 67 - 68
  • [29] Bevacizumab plus Oxaliplatin-Based Regimens for the Treatment of Colorectal Cancer
    Scheithauer, Werner
    Schmiegel, Wolff
    ONKOLOGIE, 2009, 32 (07): : 431 - 439
  • [30] Cetuximab plus oxaliplatin-based chemotherapy in the treatment of colorectal cancer
    Moosmann, Nicolas
    Heinemann, Volker
    EXPERT REVIEW OF ANTICANCER THERAPY, 2008, 8 (03) : 319 - 329
12345